Kaposi Sarcoma Clinical Trials & Research

Our physicians and researchers continue to investigate new ways to treat Kaposi sarcoma. As a patient at Memorial Sloan Kettering, you may have access to novel therapies for the disease that are not available elsewhere through one of our clinical trials. Our investigators also participate in national clinical trials, sponsored by the AIDS Malignancy Consortium, to improve the treatment of AIDS-associated KS.

Learn more about current trials for AIDS-associated KS at Memorial Sloan Kettering at the link below:

and/or
1 Clinical Trials found
A Phase 1 Study of MQ710 in People With Solid Tumors
In this study, researchers are finding the highest dose of MQ710 to use safely in people with certain types of advanced cancer. The people in this study have solid tumors that came back or grew even after treatment. In a later part of the study, the researchers will assess MQ710 plus another drug called pembrolizumab.
New York City, Commack, Basking Ridge, Westchester, Monmouth, Bergen, Nassau